A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥ 70) with stage IIIB/IV non-small cell lung cancer (NSCLC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: T. E. Stinchcombe, M. A. Socinski, J. Choksi, K. Bakri, M. Taylor, M. T. Tynan, A. Mears, C. Smith
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2243643147